The BPSA Board of Directors provides strategic direction and helps deliver member value for the organization. It consists of 19 representatives from our supplier and end-user members. Directors are elected for two-year terms.
Board Members
Jeffrey Carter, PhD
Cytiva
BPSA Chair
Mark A. Petrich, PhD PE
Krystal Biotech
BPSA First Vice-Chair
Joseph St. Laurent
Chemic Laboratories, Inc.
BPSA Second Vice-Chair
Eric Isberg
Savillex
BPSA Treasurer
Todd Andrews
CPC
Secretary
Kirsten Strahlendorf
Sanofi Pasteur
BPSA SAB Chair
Ralph Daumke
PendoTECH
Patrick Evrard
Pall Corporation
Scott Herskovitz
Qosina Corporation
Todd Kapp
Entegris, Inc.
Charlotte Masy
GSK Vaccines
Ravi Narayanan
Nordson Medical
David Radspinner
ILC Dover
Robert Sassa
W. L. Gore & Associates
Mark Sitcoske
High Purity New England
Elisabeth Vachette
Sartorius Stedim Biotech
Chairman Emeriti
Kenneth L. Bibbo
Wood PLC
Chairman Emeriti
John Boehm
CPC
Chairman Emeriti
Jerold Martin
Chairman Emeriti
Richard Sullivan
Chairman Emeriti